Predict your next investment

ELECTRONICS | Technical & Scientific Instrumentation
luxendo.eu

See what CB Insights has to offer

Total Raised

$8.99M

Investors Count

4

Deal Terms

1

Luxendo Funding, Luxendo Valuation & Luxendo Revenue

3 Fundings

Luxendo's latest funding round was a Acquired for on May 8, 2017.

Luxendo's valuation in October 2015 was $27.46M.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

5/8/2017

Acquired

2

1/12/2017

Series A - II

$99M

10

10/14/2015

Series A

$99M

$27.46M

10

Date

5/8/2017

1/12/2017

10/14/2015

Round

Acquired

Series A - II

Series A

Amount

$99M

$99M

Investors

Valuation

$27.46M

Revenue

Sources

2

10

10

Luxendo Deal Terms

1 Deal Term

Luxendo's deal structure is available for 1 funding round, including their Series A from October 14, 2015.

Round

Series A

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A

$99M

$99M

$99M

$99M

Luxendo Investors

4 Investors

Luxendo has 4 investors. Bruker invested in Luxendo's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

5/8/2017

5/8/2017

1
Acquired

Corporation

Massachusetts

00/00/0000

00/00/0000

Life Sciences Partners

Subscribe to see more

Venture Capital

Netherlands

00/00/0000

00/00/0000

EMBL Ventures

Subscribe to see more

Subscribe to see more

Venture Capital

Germany

00/00/0000

00/00/0000

EMBLEM

Subscribe to see more

Corporation

Germany

First funding

5/8/2017

00/00/0000

00/00/0000

00/00/0000

Last Funding

5/8/2017

00/00/0000

00/00/0000

00/00/0000

Investor

Life Sciences Partners

EMBL Ventures

EMBLEM

Rounds

1
Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Type

Corporation

Venture Capital

Venture Capital

Corporation

Location

Massachusetts

Netherlands

Germany

Germany

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.